← FDA Drug Approvals (Drugs@FDA)

CARBIDOPA, LEVODOPA AND ENTACAPONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2026-02-05

Drug application

FDA Application #

ANDA218535

Application type

Abbreviated New Drug Application (Generic)

Brand name

CARBIDOPA, LEVODOPA AND ENTACAPONE

Generic name

CARBIDOPA, LEVODOPA AND ENTACAPONE

Active ingredients

CARBIDOPA; ENTACAPONE; LEVODOPA

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Inc.

First approval

2026-02-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown